LAS VEGAS--(BUSINESS WIRE)--
Enterprises, Inc. (OTCBB:MDCN) a
bio-pharmaceutical company in the emerging global medical marijuana
industry is pleased to announce its joint venture partner International
Herbs Medical Marijuana Ltd ("IHMML") received conditional zoning
approval from the Corporation of Delta (often referred to as the City of
Delta, a suburb of Vancouver, British Columbia) . As previously
announced in our press release dated March 18, 2014, we are working
together with IHMML on several projects in Canada, including the project
in Delta. IHMML was founded by the owners of International Herbs Ltd
("IHL"), Western Canada's largest fresh herb grower, importer,
distributor and a leading specialty herbal produce grower in North
America, and the Monark Group ("Monark"), a full service provider of
marketing, IT solutions and outsourced service centers focused on the
Health Canada introduced a new set of regulations with regards to the
production and distribution of medical marijuana in Canada, which became
effective on April 1, 2014. Individual municipalities however, still
have to give licensed medical marijuana producers permission to operate
within its city limits. As a result Delta immediately introduced
stringent zoning regulations prohibiting medical marijuana facilities in
all zones including agricultural properties. They did however state that
applications would be considered on a case-by-case basis.
IHMML had to demonstrate that they had a competent management team,
comprehensive security plans and the support of Health Canada. In
addition, Delta had an extensive public consultation process to ensure
local residents were involved in the decision making. On May 27, 2014,
Delta unanimously approved IHMML's request to operate a 25,000 sq ft
facility subject to property taxes being paid at the industrial rate.
This rate will apply even in the event that the Provincial Government
determines that medical marijuana cultivation is an agricultural use.
The fact that IHMML received conditional approval to operate in Delta
demonstrates the caliber of the management team and their mission of
creating a world-class medical marijuana company together with Medican.
It is also important to note that IHMML is currently the only medical
marijuana company that has received permission to operate in Delta. Rick
Brar from IHMML stated that the plant would meet stringent Health Canada
requirements and described the company as "an open book, full disclosure
company." He added "we fully understand the concerns that the community
will have with regards to security, it's only natural. It's for this
reason the federal government has created these strict security
conditions and pre-conditions for license approval."
Medican CEO Ken Williams stated, "we are very pleased with this approval
in Delta. It reaffirms the wisdom of our choice of Canadian partners. We
are continually impressed with the abilities and professionalism of
everyone at IHMML."
About Medican Enterprises Inc.
Medican Enterprises is a
bio-pharmaceutical company focused on developing, distributing and
marketing pharmaceutical grade cannabis to the emerging global medical
marijuana market. It's wholly owned subsidiary Medican Systems Inc. is
an industry leader in the design, construction and operation of Medical
Marijuana and Cultivation Centers across Canada and the United States.
Traded on the OTCBB, Medican drives shareholder value through its
scalable business model and commitment to scientific research,
operational excellence and regulatory compliance. For more information
For More Information
Ken Williams, CEO | Medican Enterprises
Forward-Looking and Cautionary Statements
statements contained herein contain "forward-looking statements" within
the meaning of Section 27A of Securities Act of 1933, and Section 21E of
the Securities Exchange Act of 1934. Statements in this press release
that are not purely historical are forward-looking statements and
include any statements regarding beliefs, plans, expectations or
intentions regarding the future. Such forward-looking statements involve
known and unknown risks, uncertainties and other factors, which may
cause the actual results, performance or achievements of Medican
Enterprises Inc. to be materially different from any future results,
performance or achievements expressed or implied by such forward-looking
statements. Given these uncertainties, readers are cautioned not to
place undue reliance on such forward-looking statements. Medican
Enterprises Inc. disclaims any obligation to update or to announce
publicly the results of any revision of the forward-looking statements
contained or incorporated by reference herein to reflect future events
or developments. Although we believe that any beliefs, plans,
expectations and intentions contained in this press release are
reasonable, there can be no assurance that any such beliefs, plans,
expectations or intentions will prove to be accurate. Investors should
consult all of the information set forth herein and should also refer to
the risk factors disclosure outlined in the reports and other documents
we file with the SEC, available at www.sec.gov.
Source: Medican Enterprises, Inc.